Population-based Nationwide Study on Invasive Pneumococcal Infections Among Children (0-18 Years) in France
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
After 7 then 13 valent pneumococcal conjugate vaccine implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 1 day
Maximum Age: 18
Healthy Volunteers: f
View:
• Isolate of Streptococcus pneumoniae from at least one blood culture, or pleural fluid, or joint fluid, or cerebrospinal fluid or other normally sterile body site, or if there is a positive blood PCR.
Locations
Other Locations
France
ACTIV
RECRUITING
Créteil
Contact Information
Primary
Levy Corinne
corinne.levy@activ-france.fr
1 48 85 04 04
Backup
Bechet Stephane
stephane.bechet@activ-france.fr
1 48 85 96 68
Time Frame
Start Date: 2010-12-13
Estimated Completion Date: 2030-01-01
Participants
Target number of participants: 1369
Treatments
Cohort of invasive pneumococcal disease in children
Related Therapeutic Areas
Sponsors
Leads: Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: Pfizer